Cholines
terase Inhibitors Cholinesterase inhibitors are drugs used to treat a variety of neurological disorders, including Alzheimer's disease, myasthenia gravis, and glaucoma. These drugs work by blocking the action of the cholinesterase enzyme, an enzyme that breaks down the neurotransmitter acetylcholine in the body. By blocking this enzyme, cholinesterase inhibitors can increase levels of acetylcholine, which can help to reduce symptoms of neurological disorders. These drugs are safe and effective treatments for a number of neurological conditions, improving the quality of life for patients who suffer from them.
← Journal of Obesity ManagementRelated Articles
1 journal(s) foundObesity Management
ISSN: 2574-450X
Type: Open Access Journal
Editor-in-Chief: Amit Surve, Research Specialist,
Bariatric Medicine Institute Surgical & Medical Weight Loss Solutions,
Utah, USA.
JOM focuses on the research of eating disorders, habits and lifestyle of obese people. It aims to form a primary source for examining, diagnosing, treating and thus leading to a much healthier prospectus of obesity affected persons. Hoping that this helps clinicians all over the world to share their experiences and also to gain current information.